Status:
COMPLETED
Quantification of microRNAs in Diagnosis of Pulmonary Nodules
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Pulmonary Cancer
Eligibility:
All Genders
18+ years
Brief Summary
One of the main challenges of thoracic oncology lies in earlier diagnosis of lung cancer to improve survival rate, wich is about 15% at 5 years. This poor prognosis is often linked to late diagnosis. ...
Eligibility Criteria
Inclusion
- Patients with suspected abnormal chest X-ray image of malignancy defined by one solitary pulmonary nodule (NPS) NPS or 2 if operable, higher than 5 mm and less to 30 mm, without histological evidence.
- Affiliation to social security.
- Signature of informed consent.
Exclusion
- Nodule not accessible to curative local therapy (surgery, thermoablation, radiotherapy).
- Patients in whom resection for diagnostic purposes this emergency such as one of these characters can not be delayed (these patients are not likely to belong to the people that can take a dosage of clinical interest miRNAs because the characteristics radiographic their nodule only tell them a high probability of lung cancer)
- History of an unhealed cancer
- Patients benefiting from a system of legal protection
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03293433
Start Date
November 1 2015
End Date
May 1 2019
Last Update
July 16 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of la Réunion
La Réunion, France, 97400
2
University Hospital of Toulouse
Toulouse, France, 31059